Latest

psychedelics

This shows a psychedelic filter over a woman's face

·September 14, 2021·3 min read

LSD-Triggered Altered Behaviors Linked to Abnormal Brain Communication

Altered behaviors associated with LSD may be caused by a reduction in the normal communication between the hippocampus and visual cortex.

Featured Neuroscience Pain Psychology

·July 25, 2021·4 min read

The Future of Psychedelic Science

From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.

Featured Neuroscience Psychology

·July 5, 2021·2 min read

Psychedelic Spurs Growth of Neural Connections Lost In Depression

One dose of psilocybin, the psychoactive compound found in magic mushrooms, increases dendritic spine density within 24 hours. The neurobiological changes lasted for a month following psilocybin exposure. Additionally, mice subjected to stress showed behavioral improvements and increased neurotransmitter activity after psilocybin exposure.

This shows two mice and a stick and ball chemical structure

Featured Neuroscience Psychology

·May 25, 2021·4 min read

Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mice

A single dose of tabernanthalog (TBG), a non-hallucinogenic psychedelic analog, corrects stress-induced behavioral deficits, including anxiety and cognitive inflexibility, in mouse models. Additionally, the compound promoted neurogenesis and restores neural circuits in brain areas damaged by stress.

Featured Neuroscience Psychology

·April 28, 2021·4 min read

A Psychedelic-Like Drug Without the Hallucinogenic Side Effects

PsychLight, a newly developed genetically encoded fluorescent sensor, helped researchers identify a psychedelic compound that acts on beneficial neural pathways to treat psychiatric disorders without the hallucinogenic effect.

This shows wild psilocybin cyanescens mushrooms

Featured Neuroscience Psychology

·April 16, 2021·8 min read

Psilocybin Performs At Least As Well as Leading Antidepressant in Small Study

Psilocybin, the psychoactive compound found in magic mushrooms, is as effective at treating depression as conventional SSRI antidepressants. Researchers report, that although not significantly significant, early findings reveal those treated with psilocybin experienced more rapid and greater reductions in depression symptoms than those treated with SSRIs.

This shows the outline of a head with a half moon inside

Featured Neuroscience Psychology

·April 13, 2021·4 min read

Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits

A mouse study refutes the common belief that psilocybin's ability to produce an anti-depressant effect is attributed to the psychedelic experience it creates. Blocking the psychedelic effect did not affect psilocybin's anti-depressant effects.

This shows a blurry outline of a man in blue

Featured Neuroscience Psychology

·April 6, 2021·4 min read

Resurging Psychedelic Therapies for Depression

As interest in using psychedelics to treat a range of mental health disorders grows, researchers consider the impact and therapeutic benefits of using psychedelics to help alleviate symptoms of depression.

Featured Neuroscience Psychology

·March 27, 2021·5 min read

Psychedelic Drugs: How the Brains of Informed Users Are Different

While the effects of hallucinogens to treat mental illnesses are being researched, little is known about the neurobiology of those who dabble in psychedelics for recreational purposes. A new study reports "psychonauts" have distinct behaviors, including taking a scientific approach to documenting their experience with hallucinogens, compared to more recreational users.

This is a spiky psychedelic star which becomes an optical illusion the longer you look at it

Featured Neuroscience Open Neuroscience Articles Psychology

·March 10, 2021·7 min read

Psychedelic Science Holds Promise for Mainstream Medicine

A new study investigates psychedelic medicine on brain activity and the potential for using psychedelics to treat a range of disorders.

This shows a man's fingers holding a tiny blue triangle that looks as though it is made out of felt

Featured Neuroscience Open Neuroscience Articles Psychology

·March 2, 2021·4 min read

Placebo Effect May Explain Reported Benefits of Psychedelic Microdoses

A placebo-controlled study of psychedelics reveals the psychological benefits of microdosing are most likely explained by the placebo effect.

Featured Neuroscience Psychology

·February 21, 2021·4 min read

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

From microdosing to improve cognition, to treating a range of mental health disorders, researchers evaluate the rise in the use of psychedelics and their potential as medicines.

1 … 6 7 8 9 10 … 12

psychedelics

LSD-Triggered Altered Behaviors Linked to Abnormal Brain Communication

The Future of Psychedelic Science

Psychedelic Spurs Growth of Neural Connections Lost In Depression

Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mice

A Psychedelic-Like Drug Without the Hallucinogenic Side Effects

Psilocybin Performs At Least As Well as Leading Antidepressant in Small Study

Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits

Resurging Psychedelic Therapies for Depression

Psychedelic Drugs: How the Brains of Informed Users Are Different

Psychedelic Science Holds Promise for Mainstream Medicine

Placebo Effect May Explain Reported Benefits of Psychedelic Microdoses

From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

Why We Are Misjudging How Childhood Trauma Changes the Body

Everyday Habit Changes Lowers Dementia Risk

Legalized Cannabis Does Not Increase Consumption

Disrupted Neuronal Microexons Drive Hyperarousal and Insomnia

Subscribe